Usefulness of local urokinase-thrombolysis and massage (UKTM) therapy for patients with clotted blood access for hemodialysis.
スポンサーリンク
概要
- 論文の詳細を見る
One of the most common problems in the blood-access for hemodialysis is clotting. Urokinase (UK) is routinely used as a thrombolytic agent for peripheral or cardiac thrombosis at present. Digital manipulation is added to UK-thrombolysis (UKTM) for the patients with clotted blood access for hemodialysis. The average age of those patients was 62.5 years. The total dose of UK was 180, 000 units in average. The overall recanalization rate was 71.4% (25/35), 75% (18/24) in patients with PTFE grafts, and 63% (7/11) in those with native arteriovenous fistulas. As complications following UKTM, ecchymoses were seen in 24/25 (92%), local pain in 23/25 (92%), re-clotting with in 24 hours in 2/35 (5.7%). No serious bleeding complications nor pulmonary embolism were seen. UKTM is a safe, easy, and effective modality to treat the clotting blood access as a first choice of treatment options.
- 社団法人 日本透析医学会の論文
社団法人 日本透析医学会 | 論文
- 4．血液浄化療法の生体適合性と腎性貧血
- PD-HD併用療法においての腎機能保護の可能性 : 第51回日本透析医学会ワークショップより
- 腹部大動脈人工血管の仮性動脈瘤破裂，および右大腿回旋動脈の仮性動脈瘤破裂をきたした血液透析患者の1例
- 5．透析患者のインスリン抵抗性と腎性貧血
- 摘出腫瘤の病理組織標本所見より頸椎腫瘍状石灰沈着症 (cervical tumoral calcinosis) と診断し得た維持透析患者の1例